Laurie Smaldone Alsup's Insider Trades & SAST Disclosures
Laurie Smaldone Alsup's most recent trade in BlackBerry Ltd was a trade of 5,994 Deferred Share Unit done . Disclosure was reported to the exchange on June 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Laurie Smaldone Alsup.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BlackBerry Ltd | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 5,994 | 292,923 | - | - | Deferred Share Unit | |
| BlackBerry Ltd | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,763 | 286,929 | - | - | Deferred Share Unit | |
| Arvinas Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 9,070 | 9,070 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 5,899 | 10,020 (0%) | 0% | 0 | Common Stock | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 23,576 | 23,576 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 10,537 | 64,331 (0%) | 0% | 0 | Ordinary Shares | |
| BlackBerry Ltd | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 17,763 | 269,166 | - | - | Deferred Share Unit | |
| Arvinas Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,787 | 12,787 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 4,121 | 4,121 (0%) | 0% | 0 | Common Stock | |
| Kinnate Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,044 | 22,044 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,132 | 53,794 (0%) | 0% | 0 | Ordinary Shares | |
| Arvinas Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 10,192 | 10,192 | - | - | Stock Option (right to buy) | |
| Kinnate Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,250 | 20,250 | - | - | Stock Option (right to buy) | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 28,000 | 28,000 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 9,852 | 44,662 (0%) | 0% | 0 | Ordinary Shares | |
| Kinnate Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 20,250 | 20,250 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 7,511 | 7,511 | - | - | Stock Option (right to buy) | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 9,828 | 34,810 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,000 | 6,000 | - | - | Share Option (Right to Buy) | |
| Arvinas Inc | Laurie Smaldone Alsup | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 12,000 | 12,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges